Skip to main content

Elevance Health Inc Value Stock - Dividend - Research Selection

Anthem

ISIN: US0367521038 , WKN: A12FMV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Unpacking Elevance Health Inc (ELV)'s Market Leadership: A Deep Dive into Financial Metrics and ...

2023-09-21
Exploring the Financial Growth and Competitive Edges of Elevance Health Inc (ELV)

First Week of October 20th Options Trading For Elevance Health (ELV)

2023-09-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Elevance: Pave The Way For The Next UnitedHealth

2023-09-20
Elevance and other PBM providers have experienced massive volatility over the past few months. So, why do I rate ELV a BUY? Click here to find out.

The Zacks Analyst Blog Highlights Alibaba Group, TotalEnergies, ConocoPhillips, Elevance Health and The Charles Schwab

2023-09-20
Alibaba Group, TotalEnergies, ConocoPhillips, Elevance Health and The Charles Schwab are part of the Zacks top Analyst Blog.

Tracking Ruane, Cunniff & Goldfarb's Portfolio - Q2 2023 Update

2023-09-20
Ruane, Cunniff & Goldfarb's 13F portfolio value increased by 4% to $6.34B in Q2 2023. Read more to see the portfolio's full Q2 2023 update.

Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?

2023-09-20
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Top Stock Reports for Alibaba, TotalEnergies, ConocoPhillips & Others

2023-09-19
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), TotalEnergies SE (TTE) and ConocoPhillips (COP).

Peering Into Elevance Health's Recent Short Interest

2023-09-18
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

17 Best Low Risk Investments in 2023

2023-09-17
In this article, we will take a look at the 16 best low risk investments in 2023. To see more such companies, go directly to 5 Best Low Risk Investments in 2023. Investors are still in a wait and see mode after the latest inflation and retail sales report which give mixed signals. Some analysts […]

Dividend Champion, Contender, And Challenger Highlights: Week Of September 17

2023-09-17
Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts. Click here for the complete list.